<DOC>
	<DOCNO>NCT00005891</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine effectiveness moderate dose cyclophosphamide total lymphoid radiotherapy term improve survival reduce morbidity follow allogeneic bone marrow transplantation patient Fanconi 's aplastic anemia .</brief_summary>
	<brief_title>Study Allogeneic Bone Marrow Transplantation Following Cyclophosphamide Radiotherapy Patients With Fanconi 's Anemia</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Patients receive cyclophosphamide IV 2 hour day -6 -3 total lymphoid radiotherapy day -1 . Patients undergo allogeneic bone marrow transplantation day 0 . Patients follow least 100 day .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Fanconi Anemia</mesh_term>
	<mesh_term>Fanconi Syndrome</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>Diagnosis severe aplastic anemia typical phenotype Fanconi 's anemia : Short stature Hypoplastic radius Skin pigmentation Renal anomaly Chromosomal fragility Family history Fanconi 's anemia Histocompatible relate donor No evidence excessive vitro chromosome fragility typical Fanconi 's anemia Normal CBC bone marrow</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>54 Years</maximum_age>
	<verification_date>July 2004</verification_date>
	<keyword>Fanconi 's Anemia</keyword>
	<keyword>aplastic anemia</keyword>
	<keyword>hematologic disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>